Eui-kyung K. Lee
Gyeonggi-do, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 134 publications
Clinical Impact and Cost-effectiveness of Everolimus Combination Therapy in Liver Transplant Recipients: Focus on the Risk of Cancer, Infection, and Renal Function.
Journal: Transplantation
Published: April 23, 2026
Long-term comparative effectiveness of tepotinib versus standard of care for MET exon 14 skipping-mutated non-small cell lung cancer.
Journal: Therapeutic advances in medical oncology
Published: March 26, 2026
Age-Specific Patterns in Utilization and Costs of Developmental Rehabilitation Therapy for Children With Autism Spectrum Disorder in South Korea: A Cross-Sectional Survey.
Journal: Journal of autism and developmental disorders
Published: November 24, 2025
Variation in Attribute Prioritization and Design of Discrete Choice Experiments Across Pharmaceuticals and Medical Devices Patient Preference: A Systematic Review.
Journal: Patient preference and adherence
Published: October 27, 2025
A comparative review of economic evaluations for immune checkpoint inhibitors in early stage and advanced stage cancer: focusing on pembrolizumab.
Journal: Frontiers in pharmacology
Published: October 02, 2025
Predictive model of public health impact of herpes zoster vaccination and related costs for adults aged ≥50 years in Republic of Korea.
Journal: Human vaccines & immunotherapeutics
Published: September 26, 2025
Exploring trends of cost-effectiveness thresholds in South Korea: systematic review of pharmacoeconomic evaluations since introduction of the positive list system.
Journal: Cost effectiveness and resource allocation : C/E
Published: September 18, 2025
Patient-reported health utility of stroke and gastrointestinal bleeding related to DOACs in atrial fibrillation: a vignette-based substudy of a randomized controlled trial.
Journal: Scientific reports
Published: August 02, 2025
A matching-adjusted indirect comparison of first-line lorlatinib and alectinib for the treatment of ALK-rearranged advanced non-small cell lung cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 02, 2025
Economic Evaluation of Penpulimab Plus Paclitaxel and Carboplatin Combination Therapy as First-Line Treatment for Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer in China.
Journal: Clinical drug investigation
Published: April 07, 2025
Assessing the impact of aggressive versus intermediate LDL-C goal achievement in Asian adults: a retrospective cohort study using national health insurance service-senior cohort.
Journal: Lipids in health and disease
Published: March 24, 2025
Lifetime economic burden of hemophilia using a nationwide real-world healthcare data.
Journal: PloS one
Published: February 27, 2025
Last Updated: 09/26/2026